Stock Price

As cars become computers on wheels, ECARX is vying for the driver's seat. A key investor pitch could define its trajectory in the crowded auto-tech race.

Formerly Bit Origin, SANGRIX is cashing in its crypto holdings to chase the AI boom. But can a small Dogecoin sale fund a move into a capital-intensive industry?

Nearing its 100th anniversary, Hudbay Minerals' sharp focus on copper and operational excellence has catapulted it onto the prestigious TSX30 list.

As Vertical Aerospace courts investors, its hybrid and defense pivots will be tested. Can it secure the capital needed to clear the runway to certification?

Newly restructured Niki BioSolutions faces Wall Street at a key conference, pitching its brain health innovations while battling steep losses and investor doubt.

Spirit Blockchain Capital rebrands as Impauer Technologies, shedding its crypto-specific identity. Is this a visionary pivot or a desperate escape from a volatile market?

A century-old Hawaiian institution is going public. We look beyond the financials to see what ASB's Wall Street debut means for its community-first mission.

A major automaker's quiet bet on Hirain and Arbe's radar for Level 3 driving is more than a press release. It's a lesson in execution over rhetoric.

Michelin's new global share plan offers a steep 30% discount to 114,000 staff. Is this a savvy play for retention or a dilution risk for investors?

With sales down and its dividend cut, The Campbell's Company's new leadership faces a critical test at the upcoming Barclays investor conference.

After a sharp stock drop, digital intelligence firm Cellebrite is betting on its advanced AI strategy to win back investors. Can it prove its growth story is real?

TOYO Co., Ltd. is betting its future on controlling the entire solar supply chain. As its CSO meets investors, can this bold strategy navigate trade risks?

Facing delisting, BioRestorative executes another reverse split. We dive into whether this financial maneuver can sustain it or just delays the inevitable.

As fintech giant nCino heads to a key investor conference, its 'agentic AI banking' vision is under the microscope. What's behind the buzzword?

With massive acquisitions in Florida and beyond, PACS Group is growing at a breakneck pace. But is its REIT-fueled, 'locally led' model a new paradigm for care or a risky bet?

Granted a 180-day Nasdaq extension, AI infrastructure firm Alpha Compute must now prove its high-tech vision is more than a penny stock reality.

In a feat of operational innovation, ACG Metals transformed a Turkish gold mine into a copper producer, timing its entry perfectly with the energy transition.

Gaming giant GDEV is buying back $20M of its own shares amid falling revenue. Is this a bold signal of confidence or a defensive move in a tough market?

BioLineRx secures crucial funds for its cancer drugs, but at a cost. We dissect the deal, the shareholder dilution, and what it reveals about biotech financing.

Affirm crushes earnings estimates with a 1,300% EPS surprise, sending shares soaring. A deep dive into the BNPL leader's strategy and what it means for consumers.